Polypharmacy and Hyperglycaemia Risk in Patients with Diabetes
Polypharmacy in type 2 diabetes (T2DM) is common and linked to poorer glycaemic outcomes. How can MIMS CDS support clinicians to improve patient safety?
Implementing Clinical Decision Support System (CDSS): A Path to Success
5 minutes read time CDSS (Clinical Decision Support System) have become indispensable tools in today’s evolving healthcare landscape, helping...
Paracetamol Use in NSAID-Allergic Patients – Are You Overlooking the Cross-Sensitivity Risk?
This article outlines the mechanism, prevalence, and key risk factors for paracetamol hypersensitivity in NSAID-allergic patients and more.
Preventing Serotonin Syndrome with Clinical Decision Solutions: A Safety Imperative in Psychiatry
Serotonin syndrome is fast-moving but preventable. With psychiatric patients often prescribed serotonergic medications, clinicians must stay alert to potential risks.
The Impact of Diuretics on QT Prolongation
Diuretics can raise risk by altering serum electrolytes. This article examines the mechanisms, associated risks, and how implementing CDS can support best practices at the point of care.
Using Clinical Decision Solutions to Reduce Risks of CNS-Active Polypharmacy in the Elderly
CNS-active polypharmacy poses serious risks to elderly patients. Learn how MIMS CDS tools help improve medication safety and clinical outcomes.